In the context of prostate cancer, a positive correlation between GLO-1 expression levels and both pathological grade and proliferation rate has been reported, suggesting that GLO-1 may function as a risk factor for prostate cancer growth and disease progression (42). The gene discussed is GLO1; the disease is prostate carcinoma.